The current recessionary environment has wreaked havoc across sectors and geographies. However, while we fret at the declining value of our portfolios, this can also prove to be once in a lifetime opportunity to pick up gems at a huge discount for bargain hunters. As has been famously said by Baron Rothschild, an 18th-century British nobleman and member of the Rothschild banking family, "The time to buy is when there's blood in the streets."

According to Barron's, Bank of America analyst Geoff Meacham noted, “Despite market volatility from [coronavirus], we expect limited impact on biopharma fundamentals.” Biotech definitely seems to be one of the more resilient investments considering that they are involved in dispensing essential goods and services.

READ FULL ARTICLE HERE